Skip to content
2000
Volume 8, Issue 3
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Programmed cell death (pcd) is a form of cell death in which the cell plays an active role in its own demise. Pcd plays a critical role in the development of the nervous system, as well as in its response to insult. Both anti-pcd and pro-pcd modulators play prominent roles in development and disease, including neurodegeneration, cancer, and ischemic vascular disease, among others. Over 100,000 published studies on one form of programmed cell death—apoptosis—have appeared, but recent studies from multiple laboratories suggest the existence of non-apoptotic forms of programmed cell death, such as autophagic programmed cell death. In addition, there appear to be programmatic cell deaths that do not fit the criteria for either apoptosis or autophagic cell death, arguing that additional programs may also be available to cells. Constructing a mechanistic taxonomy of all forms of pcd—based on inhibitors, activators, and identified biochemical pathways involved in each form of pcd—should offer new insight into cell deaths associated with various disease states, and ultimately offer new therapeutic approaches.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/156652408784221315
2008-05-01
2025-12-30
Loading full text...

Full text loading...

/content/journals/cmm/10.2174/156652408784221315
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test